Fig. 4. Positive expression of GD2 and CD90 were significantly increased in glioblastoma multiforme (GBM) cells than neural stem cells (NSCs). BD Lyoplate Human Cell Surface Marker Screening showing high regulated markers of >50% were selected in GBM cells, and analyzed with the expressed changes in NSCs. Data was expressed by the fold changes of each value in GBM cells as compared with NSCs for the selected 11 markers.
